Repare Therapeutics Files 2025 DEF 14A
| Field | Detail |
|---|---|
| Company | Repare Therapeutics Inc. |
| Form Type | DEF 14A |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
TL;DR
Repare Therapeutics filed its 2025 DEF 14A, detailing exec pay and 2022-2023 financials. Look for equity award details.
AI Summary
Repare Therapeutics Inc. filed a DEF 14A on April 29, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other corporate governance matters. Key financial data for the fiscal years 2022 and 2023 are also presented, including information on equity awards granted to executives.
Why It Matters
This filing provides crucial insights into Repare Therapeutics' executive compensation structure and corporate governance, which can influence investor confidence and strategic decisions.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) that primarily concerns executive compensation and corporate governance, not immediate operational or financial distress.
Key Numbers
- 2022 — Fiscal Year (Financial data presented for this year)
- 2023 — Fiscal Year (Financial data presented for this year)
Key Players & Entities
- Repare Therapeutics Inc. (company) — Filer of the DEF 14A
- 20250429 (date) — Filing date of the DEF 14A
- 2024-12-31 (date) — Fiscal year end for which the filing is relevant
- 2022-12-31 (date) — Prior fiscal year for which financial data is presented
- 2023-12-31 (date) — Prior fiscal year for which financial data is presented
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by companies to solicit proxies from shareholders for annual or special meetings, providing detailed information on matters to be voted upon, including executive compensation, director elections, and other corporate governance issues.
What specific fiscal years' financial data is referenced in this filing?
This filing references financial data for the fiscal years ending December 31, 2022, and December 31, 2023.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on April 29, 2025.
What is the standard industrial classification for Repare Therapeutics Inc.?
The Standard Industrial Classification for Repare Therapeutics Inc. is Pharmaceutical Preparations [2834].
What is the business address of Repare Therapeutics Inc.?
The business address of Repare Therapeutics Inc. is 7171 Frederick Banting Street, Suite 270, Building 2, Saint-Laurent, Quebec, H4S 1Z9.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 29, 2025 regarding Repare Therapeutics Inc..